Search results for:

levoFLOXacin

levoFLOXacin
Brand names: Levaquin
Form Strength
SOLUTION, INTRAVENOUS 250 mg/50 mL; 500 mg/100 mL
TABLET, ORAL 250 mg; 500 mg


Medication comments:

Per policy, these drugs are subject to renal dosing adjustments by pharmacy. 
Generic + Route
(Brand)
• Indications
Usual Adult Dose
Comments
Renal Dosage Adjustments
levoFLOXacin PO/IV
(Levaquin©)
• Healthcare-associated Pneumonia (HAP) (7-14 days)
• Community-acquired Pneumonia (CAP) (5 days)
• Cellulitis
• Severe infection
750 mg q24h CrCl ≥ 50: No adjustment necessary
CrCl 20-50: 750 mg q48h
CrCl < 20: 750 mg x1, then 500 mg q48h
HD, intermittent (3x/week): 750 mg x 1 then EITHER 500 mg q48h OR 250 mg q24h
levoFLOXacin PO/IV
(Levaquin©)
• Community-acquired pneumonia (7-14 days)
• Other infections
500 mg q24h CrCl ≥ 50: No adjustment necessary
CrCl 20-50: 500 mg x1, then 250 mg q24h
CrCl < 20: 500 mg x1, then 250 mg q48h
HD, intermittent (3x/week): 500 mg x 1 then EITHER 250 mg q48h OR 125 mg q24h
levoFLOXacin PO/IV
(Levaquin©)
• Uncomplicated UTI
250 mg q24h CrCl ≥ 20: No adjustment necessary
CrCl < 20: 250 mg q48h (unless uncomplicated UTI, where no adjustment is necessary)
HD, intermittent (3x/week): 250 mg q48h
Per policy, these drugs may be converted from IV to PO in patients who meet criteria.  
Generic
(Brand)
Population IV Dose PO Dose Notes
levoFLOXacin
(Levaquin)
adult 500 mg IV q24h 500 mg PO q24h Avoid concurrent divalent and trivalent cation administration 2 hours before or 6 hours after. Avoid administration with tube feeds.
750 mg IV q24h 750 mg PO q24h
pediatric <5 y/o: 10 mg/kg q12h,
≥5 y/o: 10 mg/kg q24h
(max: 750 mg/day)
<5 y/o: 10 mg/kg q12h,
≥5 y/o: 10 mg/kg q24h
(max: 750 mg/day)
Enteral Drug Administration notes.
Generic
(Brand)
Comments and Considerations Recommendations for Administration with Enteral Nutrition
levoFLOXacin
(Levaquin)
Oral levoFLOXacin tablets with food prolongs Tmax by 1h and decreases Cmax by 14%. Oral solution with food decreased Cmax by 25% Suggest changing to IV levoFLOXacin for severe infection. No dosing changes for oral tablet. For oral solution, consider holding tube feedings 1 hour before and 2 hours after.

Last updated: Apr. 23, 2024
  • Renal Adjustment Policy levoFLOXacin subject to adjustments by pharmacy.
  • IV to PO Conversion Policy Policy
  • Black Box Warnings Tendinitis, tendon rupture
  • Look-Alike/Sound-Alike levoFLOXacin confused with levETIRAcetam


Lexicomp Online Search

Pharmacy Contact Info:

Main Inpatient Pharmacy: ext 4599, 3503
Fax: 704-878-7283

Director of Pharmacy - Randi Raynor, PharmD: ext 4501
Clinical Coordinator - Laura Rollings, PharmD: ext 4597
Pharmacy Informaticist - Stephen Pringle, PharmD: ext 7645
Pharmacy Technician Supervisor - Amy Wingler, CPhT: ext 7385
Pharmacy Automation Coordinator (Omnicell) - Melissa Fulford, CPhT: ext 3556



This site is intended for the staff of Iredell Memorial Hospital.
While others may view accessible pages, Iredell Memorial Hospital makes no warranty, express or implied,
as to the use of this information outside of Iredell Memorial Hospital.
The content of this policy and procedure document serves as guidance to the delivery of quality patient care.
Care providers are expected to exercise critical thinking and situational awareness skills,
and in specific situations to take such action as is necessary for the delivery of quality patient care.